• 23andMe Seeks FDA Approval for Health Report on Single Condition

    Bio-IT World | Today, 23andMe's new chief legal and regulatory officer, Kathy Hibbs, announced that the company has submitted a 510(k) to the FDA, seeking approval to tell customers whether they carry mutations for the rare disease Bloom syndrome. The move signals a cooperative, incremental approach to restoring the 23andMe health reports that the FDA shut down last November.

    Jun 20, 2014

  • PacBio Users Share New Tools and Applications at Meeting in Baltimore

    Bio-IT World | At the annual Pacific Biosciences user group meeting in Baltimore, geneticists and bioinformaticians gathered this week to discuss how long-read sequencing is opening up previously intractable problems. Rapid de novo assembly of whole genomes was a major topic of conversation, while users unveiled new computational tools that greatly speed up long-read assemblies, and PacBio announced plans for updated chemistry and high-throughput HLA typing.

    Jun 19, 2014

  • HudsonAlpha and University of Alabama Birmingham Launch Center for Genomic Medicine

    Alabama.com | The HudsonAlpha Institute for Biotechnology and the University of Alabama at Birmingham School of Medicine are expanding and formalizing their relationship as the UAB-HudsonAlpha Center for Genomic Medicine

    Jun 18, 2014

  • Scripps, USC Considering Joining Efforts

    San Diego Union-Tribune | The Scripps Research Institute in La Jolla and the University of Southern California are reportedly considering a merger or acquisition, under which Scripps would be acquired by USC.

    Jun 17, 2014

  • Myriad Challenges Pathway Genomics' BRCATrue Test

    Bio-IT World Brief | Ten days after Pathway Genomics announced its new BRCATrue test and its plan to donate $10 million worth of tests in its one for one program, Myriad Genetics filed a patent infringement suit against the company. While calling the suit "unwarranted", Jim Plante, Pathway Genomics' founder and CEO, also acknowledged that the lawsuit was "not unexpected."

    Jun 16, 2014

  • The Coming Wave of Generic Biologics

    Forbes | Matthew Herper examines the market for generic biotech therapies, which have sometimes been seen as more resistant to generic competition than chemically manufactured drugs.

    Jun 13, 2014

  • May-June News and Product Briefs

    Bio-IT World | News and product releases from around the industry, including Myriad Genetics donating cancer variants to PROMPT study, and the launch of MolecularHealth's cancer genotyping service.

    Jun 13, 2014

  • Moderna Remaking Itself as mRNA Startup Incubator

    Xconomy | With over $400 million on hand, Cambridge-based Moderna Therapeutics is revisiting its role in bringing mRNA-based therapies to market.

    Jun 12, 2014

  • NextCODE Brings the deCODE Data Architecture to Tumor Analysis

    Bio-IT World | NextCODE Health, the spin-off from deCODE genetics that launched last October, has continued to release new software tools based on deCODE's former diagnostic services. Its latest is a whole genome-scale tumor analyzer.

    Jun 12, 2014

  • First Reads from Nanopore Sequencers Becoming Public

    Bio-IT World News Brief | This morning, a trio of U.K. researchers released what may be the first publicly available read from an Oxford Nanopore MinION Sequencer.

    Jun 11, 2014